Astellas To Trim Workforce By 4% Due To Rising Development Costs
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma said it plans about a 4% cut in its Japan workforce by the end of the next fiscal year to compensate for an expected large increase in the cost of drug development.